Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd

Bullboard Posts

Post by AlwaysBeClosingon May 29, 2018 10:11am

277 Views

Post# 28092976

My mistake, $53M raised

Closed the purchase of the former KRAFT food manufacturing facility in Cobourg, Ontario, which is owned with no debt. The facility is an existing 620,000 sq. ft. indoor facility sitting on a 70 acre parcel of land with 40 acres primed for development. The facility has an electrical sub-station on site, natural gas lines, multiple water-intakes, rail lines directly into the facility and 26 loading docks. The facility is ideally situation just off the 401 Highway approximately 1 hour east of Toronto, ON.
$53,000,000 of equity capital raised to date and led exclusively by First Republic Capital
On October 13, 2017, FV Pharma Inc. obtained its ACMPR license to cultivate as a federally Licensed Producer
Strategic partnership through a joint-venture agreement with Cannabis Wheaton Income Corp. (TSX.V: CBW) ("Wheaton") whereby Wheaton will develop all aspects of our cultivation facility in mutually agreed staged-phases to create the largest indoor cultivation and processing facility in the world. Wheaton will receive 49.9% of all cannabis and cannabis related production from the facility, in perpetuity. It is anticipated that at full capacity this will result in FV receiving approximately 200,000,000 grams of dried cannabis flower per annum. The facility is expected to be an aggregate of approximately 3,800,000 sq. ft. at full capacity
Completed two strategic investments to deliver long-term value to our shareholders and strategically enhance and support our core operating business at the former KRAFT facility:
- High-Tide: A fully integrated retail distribution company that has applied for 31 retail cannabis permits across Canada and owns 4 prominent brands: RGR Canada Inc, Smokers Corner, Canna Cabana and subject to shareholder approval, may obtain Famous Brandz.
- Cannara Biotech Inc.: FSD currently owns 25%. Cannara plans to be the largest indoor cultivation facility in Qubec that wholly owns a 625,000 sq. ft. indoor cultivation facility on 32 acres of land strategically positioned one hour north of Montreal, QC.
Hired veteran pharmaceutical executive Michael Ash to lead the company's diversified products, pharmaceutical development and strategic growth initiatives.